Avondale Pharms

Avondale Pharmaceuticals is a specialty pharmaceutical company based in Alabama that focuses on the acquisition and commercialization of niche branded and generic prescription products. The company identifies underserved therapeutic areas and legacy medications that can be revitalized through strategic marketing or improved delivery systems. Its portfolio includes treatments for nocturia, gastrointestinal disorders, and lipid management. Avondale is notably recognized for its commercialization of Noctiva, the first FDA-approved nasal spray for nocturia, and for managing legacy brands like Niacor and NuLev. The firm operates as a private entity, leveraging a lean business model to maintain the availability of essential specialty medicines.